GABAPENTIN | A078926 | ZYDUS PHARMACEUTICALS USA INC
Highest NADAC/Unit
$0.0900
per ea
Lowest NADAC/Unit
$0.0638
per ea
Brand NDCs
0
Generic NDCs
6
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 68382020501GABAPENTIN 800 MG TABLET | $0.0900 | EA | Generic | — | 2026-08-19 |
| 68382020505GABAPENTIN 800 MG TABLET | $0.0900 | EA | Generic | — | 2026-08-19 |
| 60687051801GABAPENTIN 800 MG TABLET | $0.0900 | EA | Generic | — | 2026-08-19 |
| 68382020401GABAPENTIN 600 MG TABLET | $0.0638 | EA | Generic | — | 2026-08-19 |
| 68382020405GABAPENTIN 600 MG TABLET | $0.0638 | EA | Generic | — | 2026-08-19 |
| 60687050701GABAPENTIN 600 MG TABLET | $0.0638 | EA | Generic | — | 2026-08-19 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.